ABVC Biopharma
web2ABVC Biopharma is a clinical stage biotechnology company developing investigational medicines a...
About
ABVC Biopharma is a clinical stage biotechnology company developing investigational medicines and an ophthalmic medical device for neurological, psychiatric, cancer and eye related conditions. Its development portfolio includes candidate treatments for major depressive disorder and attention deficit hyperactivity disorder, alongside Vitargus, a proposed vitreous substitute for eye surgery. The company licenses technology originating from research institutions and works with development partners on clinical studies and potential commercialization arrangements. Its programs are at different investigational stages and should not be described as broadly approved or commercially marketed therapies. ABVC also holds interests in development related subsidiaries and assets.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
ABVC Biopharma profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy